NRF2 Pathway Status and Maintenance Immunotherapy Exposure in EC-CRT-002

Qi Cheng1, Yujin Xu1

  • 1Qi Cheng, MD and Yujin Xu, MD, Department of Thoracic Radiotherapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.

Abstract

No abstract available in PubMed .